Lee Yuchun's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Apr 18, 2022
- Accession no.
- 0000899243-22-014962
- Filed
- Apr 18, 2022
- Trade date
- Apr 14, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $578.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee YuchunCIK 0001334365 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | Common Stock | MOption exerciseAcquired | +2,000 | $81.54 | +$163,080 | 3,875 | Direct | |
| Apr 14, 2022 | Common Stock | SSaleDisposed | −948 | $287.87F2,F3 | −$272,900.76 | 2,927 | Direct | |
| Apr 14, 2022 | Common Stock | SSaleDisposed | −252 | $288.92F2,F4 | −$72,807.84 | 2,675 | Direct | |
| Apr 14, 2022 | Common Stock | SSaleDisposed | −400 | $289.84F2,F5 | −$115,936 | 2,275 | Direct | |
| Apr 14, 2022 | Common Stock | SSaleDisposed | −400 | $291.18F2,F6 | −$116,472 | 1,875 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 2,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $287.87 (range $287.49 to $288.26).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $288.92 (range $288.51 to $289.24).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $289.84 (range $289.69 to $289.96).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $291.18 (range $290.80 to $291.64).
Referenced by the price of 1 transaction in Table I.